搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
18 小时
Olema股票成为买入目标,高盛强调KAT6抑制剂的前临床数据前景可观
分析师表示,对氟维司群单药治疗的不敏感性影响了评估这些治疗组合效果的能力。尽管存在这些担忧,但这些发现似乎并未影响高盛对Olema Pharmaceuticals前景的信心,因为买入评级和目标价均得以维持。分析师的评论建议谨慎解读前临床结果,考虑到研究模型中观察到的局限性。
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
DOJ reaches settlement
DA urges resentencing
Workers reject new contract
Grizzly bear fatally struck
Sued over E. coli outbreak
Hikes annual pass prices
Funeral home owners guilty
Kristy now Category 4
Ohio abortion ban blocked
Data privacy violations fine
PA provisional ballot ruling
Nigeria releases US exec
US new home sales rise
To join Harris at rally
Reporter struck by shrapnel
Florida sues Garland
Georgia citizenship audit
CO elephants' rights case
Grammy-winning singer dies
Arbery case retrial motions
Philly synagogue targeted
LA Times editor quits
Weekly jobless claims fall
Mailbox fire damages ballots
Sued by ‘ring boys'
US charges media tycoon
Israeli strike on school
Georgia repels cyberattack
$135 million in Gaza aid
Oldest person in US dies
反馈